II. FUTURE TUBERCULOSIS CONTROL IN JAPAN
II. これからの日本の結核対策

Yasuyuki CHIBA
1972 Kekkaku (Tuberculosis)  
Future tuberculosis control in Japan was discussed on the following 2 parts. I. The Recent Trend of Tuberculosis Incidence and Method of Case-finding 1. Almost all newly detected tuberculosis cases requiring treatment have been originating from previously infected persons remote from primary infection, and the incidence of primary tuberculosis occurring from the newly tuberculin-converted persons has remarkably been reduced. (MAEDA) 2. The incidence rate of tuberculosis among the
more » ... d has been reduced to 1/12 as that 15 years before. However, the severity of tuberculosis at the time of detection has not been changed. (MAEDA, KURIHARA) 3. From the pathogenetical standpoints, tuberculous foci detected in the already-infected were assumed to result not from exogenous reinfection, but from the reactivation of the exsisting old primary foci. (MAEDA) 4. In the community where mass X-ray surveys are not annualy carried out , case-finding shoud be concentrated to persons complaning of respiratory symptoms. (YAMAGUCHI, SHIMAO) 5. The mass X-ray surveys should be focussed on high-risk areas or groups. (TOKUCHI) 6. The prevalence of healed as well as active tuberculous findings among children proved to be a useful indicator for estimating the prevalence of tuberculosis in the same community . (TOKUCHI, SAKAI) 7. Slim or thin persons were regarded as a higher-risk group than obese persons . (TO KUCHI, SAKAI, MAEDA, KURIHARA) 8. It was revealed that the intensity of primary infection gave a long-standing influence on the incidence of tuberculosis in the already-infected. (MAEDA , KURIHARA) II. Treatment and Supervision of Tuberculosis Patients 1. The indication of ambulatory treatment was discussed from various points of view . It was concluded that the non-cavitary cases, either bacilli positive or negative, could be treated effectively on ambulatory basis. (YAMAGUCHI, YAMAMOTO, SHIMAO) 2. The cavitary cases with less extensive lesions could be treated effectively by a short *From the J .N.R. Central Hospital, 2-1, Yoyogi, Shibuya-ku, Tokyo 151 Japan. 3 1 6 結 核 第 47 巻 第 9 号 term (6 to 12 months) hospitalization. (TOKUCHI, YAMAMOTO) 3. The optimal duration of chemotherapy was discussed on the basis of relapse rate after the discontinuation of chemotherapy. In the noncavitary group, the 1.5 to 2.0 years' chemo therapy was neccessary and sufficient.
doi:10.11400/kekkaku1923.47.315 fatcat:6xwltywobnf5jnchbdxs3kwwqa